Jeffrey A. Gelfand
Corporate Officer/Principal at Brighton Biotech, Inc.
Profile
Jeffrey A.
Gelfand is currently a Scientific Advisor at Brighton Biotech, Inc. He was previously an Advisor at Maxwell Asset Management LLC (US).
Jeffrey A. Gelfand active positions
| Companies | Position | Start |
|---|---|---|
Brighton Biotech, Inc.
 Brighton Biotech, Inc. BiotechnologyHealth Technology Brighton Biotech, Inc. provides medical research services. It specializes in acquiring and developing pharmaceutical and biotechnology products intended for the treatment and prevention of serious unmet medical needs. The company was founded in 2010 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Former positions of Jeffrey A. Gelfand
| Companies | Position | End |
|---|---|---|
Maxwell Asset Management LLC (US)
 Maxwell Asset Management LLC (US) Investment ManagersFinance Founded in 2003, Maxwell Asset Management LLC is a venture capital firm located in Boston. The firm is a subsidiary of Moscow-based Maxwell Capital Group LLC. They manage the Maxwell Biotech Venture Fund, Russia's first venture fund focused on the medical and biotechnology sectors. The fund is one of the first venture funds formed with the participation of the Russian Venture Company (RVC), a fund-of-funds created by the Russian government to promote the development of the venture capital industry and an innovation-based economy. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Maxwell Asset Management LLC (US)
Maxwell Asset Management LLC (US) Investment ManagersFinance Founded in 2003, Maxwell Asset Management LLC is a venture capital firm located in Boston. The firm is a subsidiary of Moscow-based Maxwell Capital Group LLC. They manage the Maxwell Biotech Venture Fund, Russia's first venture fund focused on the medical and biotechnology sectors. The fund is one of the first venture funds formed with the participation of the Russian Venture Company (RVC), a fund-of-funds created by the Russian government to promote the development of the venture capital industry and an innovation-based economy. | Finance |
Brighton Biotech, Inc.
Brighton Biotech, Inc. BiotechnologyHealth Technology Brighton Biotech, Inc. provides medical research services. It specializes in acquiring and developing pharmaceutical and biotechnology products intended for the treatment and prevention of serious unmet medical needs. The company was founded in 2010 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Jeffrey A. Gelfand
